Peter Anevski News Today

In this article, we will look at the 20 highest paid CEOs in the US and their college degrees. We have also discussed the relevance of college degrees with CEOs. If you want to skip our detailed analysis, head straight to the 5 Highest Paid CEOs in the US and Their College Degrees. In a […]

Shares of fertility-solutions company Progyny are tumbling on disappointing guidance. The company says the Alabama court ruling on in vitro...

Canaccord Genuity Group assumed coverage on shares of Progyny (NASDAQ:PGNY – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. The brokerage issued a buy rating and a $46.00 target price on the stock. Other research analysts have also issued research reports about the company. Truist Financial lifted their price […]

Macquarie Group Ltd. decreased its position in Progyny, Inc. (NASDAQ:PGNY – Free Report) by 61.1% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,940,810 shares of the company’s stock after selling 3,047,979 shares during the period. Macquarie Group Ltd. owned about 2.06% of Progyny worth $62,339,000 […]

Shares of Progyny, Inc. (NASDAQ:PGNY – Get Free Report) have earned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among […]

Progyny (NASDAQ:PGNY – Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.05, Briefing.com reports. The firm had revenue of $279.40 million for the quarter, compared to analyst estimates of $261.91 million. Progyny had a net margin […]

Progyny, Inc. (NASDAQ:PGNY – Get Free Report) was up 9.3% during mid-day trading on Friday following a stronger than expected earnings report. The stock traded as high as $44.95 and last traded at $44.18. Approximately 230,627 shares changed hands during trading, a decline of 72% from the average daily volume of 821,116 shares. The stock […]

Shares of Progyny, Inc. (NASDAQ:PGNY – Get Free Report) have earned an average rating of “Moderate Buy” from the six research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective […]

Pacer Advisors Inc. lessened its stake in Progyny, Inc. (NASDAQ:PGNY – Free Report) by 41.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,460 shares of the company’s stock after selling 5,956 shares during the period. Pacer Advisors Inc.’s holdings in Progyny were […]

Progyny, Inc. (NASDAQ:PGNY – Get Free Report) CEO Peter Anevski sold 32,000 shares of Progyny stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $38.94, for a total value of $1,246,080.00. Following the completion of the transaction, the chief executive officer now owns 207,947 shares […]